These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20577660)

  • 41. Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial.
    Arkinstall W; Sandler A; Goughnour B; Babul N; Harsanyi Z; Darke AC
    Pain; 1995 Aug; 62(2):169-178. PubMed ID: 8545142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended-release tramadol hydrochloride/acetaminophen fixed-dose combination tablet for the treatment of chronic low back pain.
    Lee JH; Lee CS;
    Clin Ther; 2013 Nov; 35(11):1830-40. PubMed ID: 24183364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of immediate-release opioids as supplemental analgesia during management of moderate-to-severe chronic pain with buprenorphine transdermal system.
    Silverman S; Raffa RB; Cataldo MJ; Kwarcinski M; Ripa SR
    J Pain Res; 2017; 10():1255-1263. PubMed ID: 28579823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients.
    Griessinger N; Sittl R; Likar R
    Curr Med Res Opin; 2005 Aug; 21(8):1147-56. PubMed ID: 16083522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients naïve to potent opioids.
    Breivik H; Ljosaa TM; Stengaard-Pedersen K; Persson J; Aro H; Villumsen J; Tvinnemose D
    Scand J Pain; 2010 Jul; 1(3):122-141. PubMed ID: 29913983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy, Safety, and Tolerability of Fulranumab as an Adjunctive Therapy in Patients With Inadequately Controlled, Moderate-to-Severe Chronic Low Back Pain: A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Dose-loading Phase II Study.
    Sanga P; Polverejan E; Wang S; Kelly KM; Thipphawong J
    Clin Ther; 2016 Jun; 38(6):1435-1450. PubMed ID: 27101815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
    Mitra F; Chowdhury S; Shelley M; Williams G
    Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Transdermal buprenorphine for treatment of chronic tumor and non-tumor pain].
    Likar R; Griessinger N; Sadjak A; Sittl R
    Wien Med Wochenschr; 2003; 153(13-14):317-22. PubMed ID: 12924108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.
    Wininger SJ; Miller H; Minkowitz HS; Royal MA; Ang RY; Breitmeyer JB; Singla NK
    Clin Ther; 2010 Dec; 32(14):2348-69. PubMed ID: 21353105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of tramadol in treatment of chronic low back pain.
    Schnitzer TJ; Gray WL; Paster RZ; Kamin M
    J Rheumatol; 2000 Mar; 27(3):772-8. PubMed ID: 10743823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain.
    Katz N; Rauck R; Ahdieh H; Ma T; Gerritsen van der Hoop R; Kerwin R; Podolsky G
    Curr Med Res Opin; 2007 Jan; 23(1):117-28. PubMed ID: 17257473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine.
    Koltzenburg M; Pokorny R; Gasser UE; Richarz U
    Pain; 2006 Dec; 126(1-3):165-74. PubMed ID: 16901645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of abuse, suspected suicidal intent, and fatalities related to the 7-day buprenorphine transdermal patch versus other opioid analgesics in the National Poison Data System.
    Coplan PM; Sessler NE; Harikrishnan V; Singh R; Perkel C
    Postgrad Med; 2017 Jan; 129(1):55-61. PubMed ID: 27922764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tolerability of Biphasic-Release Hydrocodone Bitartrate/Acetaminophen Tablets (MNK-155): A Phase III, Multicenter, Open-Label Study in Patients With Osteoarthritis or Chronic Low Back Pain.
    Zheng Y; Kostenbader K; Barrett T; Hisaw E; Giuliani MJ; Chen Y; Young JL
    Clin Ther; 2015 Jun; 37(6):1235-47. PubMed ID: 25913923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study.
    Hale ME; Ahdieh H; Ma T; Rauck R;
    J Pain; 2007 Feb; 8(2):175-84. PubMed ID: 17145204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of the Abuse and Diversion of the Buprenorphine Transdermal Delivery System.
    Wiegand TJ; Le Lait MC; Bartelson BB; Dart RC; Green JL
    J Pain; 2016 Jun; 17(6):745-52. PubMed ID: 26996928
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analgesic efficacy and safety of tramadol/ acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial.
    Peloso PM; Fortin L; Beaulieu A; Kamin M; Rosenthal N;
    J Rheumatol; 2004 Dec; 31(12):2454-63. PubMed ID: 15570651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase.
    Gordon A; Callaghan D; Spink D; Cloutier C; Dzongowski P; O'Mahony W; Sinclair D; Rashiq S; Buckley N; Cohen G; Kim J; Boulanger A; Piraino PS; Eisenhoffer J; Harsanyi Z; Darke AC; Michalko KJ
    Clin Ther; 2010 May; 32(5):844-60. PubMed ID: 20685494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of moderate or severe acute low back pain.
    Palangio M; Morris E; Doyle RT; Dornseif BE; Valente TJ
    Clin Ther; 2002 Jan; 24(1):87-99. PubMed ID: 11833838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.